1.
Oehler VG, Berman E, Huang IJ. Management of chronic myeloid leukemia with tyrosine kinase inhibitors: adverse events, toxicities and therapy dosing. haematol [Internet]. 2020Sep.10 [cited 2026Mar.12];. Available from: https://haematologica.org/article/view/13384